|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/113 | |
| A61P 9/00 | |||
| A61K 47/54 | |||
| A61K 45/06 |
| (11) | Patento numeris | 3146049 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15727527.2 |
| Europos patento paraiškos padavimo data | 2015-05-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-03-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/032099 |
| Data | 2015-05-22 |
| (87) | Numeris | WO 2015/179724 |
| Data | 2015-11-26 |
| (30) | Numeris | Data | Šalis |
| 201462001731 P | 2014-05-22 | US | |
| 201462047978 P | 2014-09-09 | US |
| (72) |
FOSTER, Donald, US
BETTENCOURT, Brian, US
CHARISSE, Klaus, US
HINKLE, Gregory, US
KUCHIMANCHI, Satyanarayana, US
MAIER, Martin, US
MILSTEIN, Stuart, US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (54) | ANGIOTENSINOGEN (AGT) IRNA COMPOSITIONS AND METHODS OF USE THEREOF |
| ANGIOTENSINOGEN (AGT) IRNA COMPOSITIONS AND METHODS OF USE THEREOF |